About the study

The purpose of this randomized study is to assess safety and effectiveness of BMS-986263 in adults with compensated cirrhosis (chronic liver disease) from nonalcoholic steatohepatitis (fatty liver disease) (NASH).

Who can take part?

You may be eligible to participate in the study if you meet the following criteria:

Inclusion criteria

1. Participants with liver biopsy fibrosis score stage 4 (NASH CRN) performed within 6 months
2. Men and women must agree to follow methods of contraception

Exclusion criteria

1. Worsening liver disease or any disease might compromise participant safety in the opinion of the investigator
2. Known immunocompromised status or any disease or condition which might compromise participant safety
3. Prior exposure to BMS-986263
4. Clinically relevant abnormal physical examination, vital signs, ECG, or clinical laboratory tests
5. Hepatic decompensation Other protocol-defined inclusion/exclusion criteria apply

For a full list of inclusion/exclusion criteria, please visit ClinicalTrials.gov

Study locations

Enter your ZIP code/Postal code/PIN code to locate study sites near you:

How to apply

Determine if a study site for this clinical trial is near you. Contact the study to apply.